High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma

Carbohydrate antigen 19‐9 (CA19‐9) fails to demonstrate the predictive value for early detection pancreatic ductal adenocarcinoma (PDAC). Glypican‐1 (GPC1+) exosomes may serve as a noninvasive diagnostic tool to detect early stages of PDAC. Therefore, it is necessary to explore the serum GPC1 levels...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Med
Päätekijät: Zhou, Cong‐ya, Dong, Yi‐ping, Sun, Xiao, Sui, Xin, Zhu, Hong, Zhao, Ya‐qin, Zhang, Yuan‐yuan, Mason, Clifford, Zhu, Qing, Han, Su‐xia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2018
Aiheet:
Clinical Cancer Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6246926/
https://ncbi.nlm.nih.gov/pubmed/30358133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1833
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia